The Potential Role of Cellular Senescence in Non-Alcoholic Fatty Liver Disease
Open accessThe DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Abstract
Non-alcoholic fatty liver disease (NAFLD) represents an increasing global health burden. Cellular senescence develops in response to cellular injury, leading not only to cell cycle arrest but also to alterations of the cellular phenotype and metabolic functions. In this review, we critically discuss the currently existing evidence for the involvement of cellular senescence in NAFLD in order to identify areas requiring further exploration. Hepatocyte senescence can be a central pathomechanism as it may foster intracellular fat accumulation, fibrosis and inflammation, also due to secretion of senescence-associated inflammatory mediators. However, in some non-parenchymal liver cell types, such as hepatic stellate cells, senescence may be beneficial by reducing the extracellular matrix deposition and thereby reducing fibrosis. Deciphering the detailed interaction between NAFLD and cellular senescence will be essential to discover novel therapeutic targets halting disease progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Disease progression in fatty liver disease. Obesity and metabolic disorders represent risk factors for NAFLD, which starts with fat accumulation in hepatocytes. Further disease progression is characterized by inflammation (NASH) and subsequent fibrogenesis leading to cirrhosis. NASH with and without cirrhosis bears the risk of developing hepatocellular carcinoma (HCC) [5,6,20].](https://figures.cochat.ai/paper-figures/23d01315a94e420ca4374747008d0181/the-potential-role-of-cellular-senescence-in-non-alcoholic-fatty-liver-disease-figure-1.jpg)
![Figure 2 Mechanisms of cellular senescence. Cellular senescence can have various triggers such as telomere shortening, DNA damage, oncogene activation and mitochondria-related factors such as reactive oxygen species (ROS) and mitochondrial DNA damage. Upon injury, the DNA damage response (DDR) mechanisms are activated and signal transduction through protein phosphorylation of ATM, ATR, CHKs stabilizes p53, thus inducing cell cycle arrest through RB. Senescence cells show high expression of p16 and p21 and high activity of SA-β-gal and secrete cytokines and chemoattractants via SASP (modified from Di Micco R et al. [30]).](https://figures.cochat.ai/paper-figures/ed7d67bcdfc94bc79bbe9dd77c47374a/the-potential-role-of-cellular-senescence-in-non-alcoholic-fatty-liver-disease-figure-2.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, driven by signalling pathways such as NOTCH1, SASP cells contribute to a pro-inflammatory microenvironment by secreting inflammatory cytokines, growth factors and matrix-degrading enzymes which have been implicated in the progression of NASH.45,46”
From Understanding the cellular interactome of non-alcoholic fatty liver disease (2022) · cites this paper as [45]
Experimental — accuracy not yet measuredIn the citing paper
“Key responses of hepatocytes to metabolic injury include the activation of inflammatory and pro-apoptotic signalling, e.g. via tumour necrosis factor (TNF)α and NF-κB,3 favouring hepatocyte cell death pathways and/or senescence.16,17”
From An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH (2023) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
Eslam, M., Newsome, P. N., Sarin, S. K., Anstee, Q. M., Targher, G., Romero-Gomez, M., Zelber-Sagi, S., Wai-Sun Wong, V., Dufour, J.-F., Schattenberg, J. M., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.03.039 · Cited by 4,472
Mechanisms of NAFLD development and therapeutic strategies
Friedman, S. L., Neuschwander-Tetri, B. A., Rinella, M., & Sanyal, A. J. (2018) · Nature Medicine · doi:10.1038/s41591-018-0104-9 · Cited by 4,354
Cellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818
Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome
Marchesini, G., Bugianesi, E., Forlani, G., Cerrelli, F., Lenzi, M., Manini, R., Natale, S., Vanni, E., Villanova, N., Melchionda, N., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50161 · Cited by 2,679
Inflammation, metaflammation and immunometabolic disorders
Hotamisligil, G. S. (2017) · Nature · doi:10.1038/nature21363 · Cited by 2,570 · cited 1×
“Hepatocyte fat accumulation and inflammation are the main drivers of disease progression [12,13] and the subsequent hepatocellular injury is characterized by alterations of the cellular function.”
BackgroundInflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
Henao-Mejia, J., Elinav, E., Jin, C., Hao, L., Mehal, W. Z., Strowig, T., Thaiss, C. A., Kau, A. L., Eisenbarth, S. C., Jurczak, M. J., et al. (2012) · Nature · doi:10.1038/nature10809 · Cited by 2,435
Estes, C., Razavi, H., Loomba, R., Younossi, Z., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29466 · Cited by 2,399
Cellular senescence in ageing: from mechanisms to therapeutic opportunities
Di Micco, R., Krizhanovsky, V., Baker, D., & d’Adda di Fagagna, F. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00314-w · Cited by 2,277 · cited 4×
“Upon injury, the DDR forms a complex of DNA response factors, including phosphorylated H2AX (γH2AX), MDC1, 53BP1 and activated ataxia telangiectasia mutated (ATM), creating foci surrounding the damaged areas [30].”
BackgroundInfluentialPersistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion
Rodier, F., Coppé, J.-P., Patil, C. K., Hoeijmakers, W. A. M., Muñoz, D. P., Raza, S. R., Freund, A., Campeau, E., Davalos, A. R., & Campisi, J. (2009) · Nature Cell Biology · doi:10.1038/ncb1909 · Cited by 2,232
Cited by
Peiseler, M., Schwabe, R., Hampe, J., Kubes, P., Heikenwälder, M., & Tacke, F. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.06.012 · Cited by 564
Self-citationAn integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH
Tacke, F., Puengel, T., Loomba, R., & Friedman, S. L. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.03.038 · Cited by 321
Self-citationUnderstanding the cellular interactome of non-alcoholic fatty liver disease
Wallace, S. J., Tacke, F., Schwabe, R. F., & Henderson, N. C. (2022) · JHEP Reports · doi:10.1016/j.jhepr.2022.100524 · Cited by 116
Self-citationThe Multifaceted Roles of Macrophages in NAFLD Pathogenesis
Vonderlin, J., Chavakis, T., Sieweke, M., & Tacke, F. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.03.002 · Cited by 96
“In NASH, a proinflammatory hepatic microenvironment stimulates fibrogenic processes leading to liver fibrosis and, eventually, cirrhosis.(3) The only curative therapy for end-stage liver disease and the early stages of hepatocellular carcinoma is liver transplantation.”
BackgroundSelf-citationZhang, C.-Y., Tan, X., Yang, H., Jin, L., Hong, J., Zhou, Y., & Huang, X. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158267 · Cited by 98
Immunopathogenic mechanisms and immunoregulatory therapies in MASLD
He, Y., Chen, Y., Qian, S., van Der Merwe, S., Dhar, D., Brenner, D. A., & Tacke, F. (2025) · Cellular & Molecular Immunology · doi:10.1038/s41423-025-01307-5 · Cited by 81
“Furthermore, hepatocyte senescence exacerbates this in fl ammatory cascade through the senescence-associated secretory phenotype (SASP) [139].”
Self-citationDu, K., Umbaugh, D. S., Wang, L., Jun, J. H., Dutta, R. K., Oh, S., Ren, N., Zhang, Q., Ko, D. C., Ferreira, A., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57616-w · Cited by 67
Role of ammonia in NAFLD: An unusual suspect
Thomsen, K. L., Eriksen, P. L., Kerbert, A. J. C., Chiara, F. D., Jalan, R., & Vilstrup, H. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2023.100780 · Cited by 72
Spatial genomics: mapping human steatotic liver disease
Matchett, K. P., Paris, J., Teichmann, S. A., & Henderson, N. C. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-00915-2 · Cited by 60
Chronic hyperinsulinemia promotes human hepatocyte senescence
Baboota, R. K., Spinelli, R., Erlandsson, M. C., Brandão, B. B., Lino, M., Yang, H., Mardinoğlu, A., Bokarewa, M. I., Boucher, J., Kahn, C. R., et al. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101558 · Cited by 230
Antifibrotic therapies for metabolic dysfunction-associated steatotic liver disease
Schwabe, R. F., Tacke, F., Sugimoto, A., & Friedman, S. L. (2025) · JHEP Reports · doi:10.1016/j.jhepr.2025.101421 · Cited by 70
Self-citationImmune surveillance of senescence: potential application to age-related diseases
Wang, T., & Nakanishi, M. (2024) · Trends in Cell Biology · doi:10.1016/j.tcb.2024.06.007 · Cited by 54
Cellular senescence in hepatocytes contributes to metabolic disturbances in NASH
Bonnet, L., Alexandersson, I., Baboota, R. K., Kroon, T., Oscarsson, J., Smith, U., & Boucher, J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.957616 · Cited by 49
Autophagy and senescence: the molecular mechanisms and implications in liver diseases
Li, Q., Lin, Y., Liang, G., Xiao, N., Zhang, H., Yang, X., Yang, J., & Liu, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316880 · Cited by 43
“Serine/cysteine proteinase inhibitors (SERPINs), candidate biomarkers of cellular senescence, can remodel the ECM [159].”
BackgroundDashti, Z. J. S., Yousefi, Z., Kiani, P., Taghizadeh, M., Maleki, M. H., Borji, M., Vakili, O., & Shafiee, S. M. (2024) · Metabolism · doi:10.1016/j.metabol.2024.155811 · Cited by 38
What are the common downstream molecular events between alcoholic and nonalcoholic fatty liver?
Tarantino, G., & Citro, V. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02031-1 · Cited by 40
A nutrigeroscience approach: Dietary macronutrients and cellular senescence
Calubag, M. F., Robbins, P. D., & Lamming, D. W. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.07.025 · Cited by 35
Danpanichkul, P., Ng, C. H., Muthiah, M. D., Duangsonk, K., Yong, J. N., Tan, D. J. H., Lim, W. H., Wong, Z. Y., Syn, N. L. X., Tsusumi, T., et al. (2023) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17714 · Cited by 35
Understanding the Unique Microenvironment in the Aging Liver
Zhao, Y., Yang, Y., Li, Q., & Li, J. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.842024 · Cited by 33
Delineating the heterogeneity of senescence-induced-functional alterations in hepatocytes
Kumar, P., Hassan, M., Tacke, F., & Engelmann, C. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05230-2 · Cited by 31
Self-citationModulation of Oxidative Stress-Induced Senescence during Non-Alcoholic Fatty Liver Disease
Pedroza-Díaz, J., Arroyave-Ospina, J. C., Salas, S. S., & Moshage, H. J. (2022) · Antioxidants · doi:10.3390/antiox11050975 · Cited by 31
Tsomidis, I., Tsakou, A., Voumvouraki, A., & Kouroumalis, E. (2026) · Biomedicines · doi:10.3390/biomedicines14010151 · Cited by 24
Flensted-Jensen, M., Oró, D., Rørbeck, E. A., Zhang, C., Madsen, M. R., Madsen, A. N., Norlin, J., Feigh, M., Larsen, S., & Hansen, H. H. (2024) · BMC Gastroenterology · doi:10.1186/s12876-024-03141-x · Cited by 17
Role of regulatory T cells in inflammatory liver diseases
Yang, L., & Zheng, S. G. (2025) · Autoimmunity Reviews · doi:10.1016/j.autrev.2025.103806 · Cited by 19
Senescent hepatic stellate cells drive inflammation and disease progression in MASH (Review)
Han, Z., She, Y., Wu, D., Zhang, N., Liu, Z., Wang, Z., Zhou, X., & Li, S. (2026) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2026.13090 · Cited by 15
The multifunctional protein CCN1/CYR61: Bridging physiology and disease
Kerek, R., Awad, J. S., Bassam, M., Hajjar, C., Ghantous, F., Rizk, K., & Rima, M. (2025) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2025.104969 · Cited by 14
Dorochow, E., Kraus, N., Chenaux-Repond, N., Pierre, S. C., Kolbinger, A., Geißlinger, G., Ortiz, C., Welsch, C., Trebicka, J., Gurke, R., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210351 · Cited by 13
Loss of Cdkn1a protects against MASLD alone or with alcohol intake by preserving lipid homeostasis
Lamas‐Paz, A., Gutierrez, A. H., Guo, F., Jorquera, G., Morán-Blanco, L., Benedé‐Ubieto, R., Mesquita, M., Estévez‐Vázquez, O., Zheng, K., Mazariegos, M. S., et al. (2024) · JHEP Reports · doi:10.1016/j.jhepr.2024.101230 · Cited by 15
Liver-Derived Exosomes Induce Inflammation and Lipogenesis in Mice Fed High-Energy Diets
Lee, J., Jeong, I., & Kim, O. (2022) · Nutrients · doi:10.3390/nu14235124 · Cited by 12
Kasper, P., Selle, J., Vohlen, C., Wilke, R., Kuiper-Makris, C., Klymenko, O., Bae‐Gartz, I., Schömig, C., Quaas, A., Schumacher, B., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105609 · Cited by 12
Chen, X., Wu, F., Chen, C., Ren, Q., & Zhang, A. (2024) · Biological Trace Element Research · doi:10.1007/s12011-023-04021-3 · Cited by 11
Dynamics of cellular plasticity in non-alcoholic steatohepatitis (NASH)
Rajak, S. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167102 · Cited by 11
Zhang, Y., Qu, J., Luo, R., Jia, K., Fan, G., Li, F., Wu, R., Li, J., & Li, X. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155923 · Cited by 10
Kourti, M., & Kontoghiorghes, G. J. (2025) · Antioxidants · doi:10.3390/antiox15010015 · Cited by 11
Zhong, H., Liu, C., Huang, Z., Tan, P., Chen, H., & Fu, W. (2025) · American Journal Of Pathology · doi:10.1016/j.ajpath.2025.02.003 · Cited by 10
Mitochondria–endoplasmic reticulum contact sites in hepatocytic senescence
Kumar, P., Hassan, M., Tacke, F., & Engelmann, C. (2026) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-025-00809-4 · Cited by 10
Self-citationTian, T., Xue, Y., Song, Z., Jin-Smith, B., Barkin, J., Ottallah, M., Mannan, M., Zhirkova, A. M., Zhou, D., & Pi, L. (2025) · GeroScience · doi:10.1007/s11357-025-01952-8 · Cited by 7
Tarantino, G., Cataldi, M., & Citro, V. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1319897 · Cited by 7
Fei, B., Wang, H., Ding, Y., Shao, N., Wen, P., Cao, Y., Li, J., Tanaka, M., Wang, Z., & Li, S. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.101996 · Cited by 11
Yang, J., Tan, H., Li, S., Yao, H., Nie, Q., Cui, S. W., & Nie, S. (2025) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5c05443 · Cited by 6
Wang, G., Mao, Z., Zhou, X. J., Zou, Y., & Zhao, M. (2022) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo-22-662 · Cited by 6
Deciphering the Role of Oroxylin A in Liver Fibrosis
Wang, S., Wu, J., Sun, J., Chen, W., Tian, Z., Huang, S., & Wang, M. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s530387 · Cited by 4
Zhao, J., Li, C., Li, Q., Shen, S., Hu, X., Dong, Z., Zhang, Y., & Xing, J. (2023) · Analytical Cellular Pathology · doi:10.1155/2023/5735339 · Cited by 5
Campos-Espinosa, A., Guzmán, C., Medina-Ávila, K. Z., & Gutiérrez‐Reyes, G. (2024) · Cells · doi:10.3390/cells13030282 · Cited by 3
ROS-associated metabolic disorders: Molecular mechanism and stem cell therapy
Debnath, B., Das, J., Bhui, U., Dewan, D., Paul, D., Mondal, M., Islam, A., Bhattacharjee, B., Ashique, S., & Hussain, M. S. (2026) · Pathology - Research and Practice · doi:10.1016/j.prp.2026.156457 · Cited by 3
Yang, R., Xu, J., Zhao, F., Sun, X., Li, Y., Zhang, Y., Peng, H., Ding, L., & Guo, B. (2026) · Clinica Chimica Acta · doi:10.1016/j.cca.2026.121015 · Cited by 2
Lan, T., Wang, W., Zeng, X.-X., Mao, W.-L., Lu, T., & Wang, S. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.158244 · Cited by 3
Liver Steatosis: From Lipotoxicity to Cellular Damage
Puengel, T., & Tacke, F. (2024) · Springer eBooks · doi:10.1007/978-981-97-9519-2_4 · Cited by 3
Self-citationClinical significance of hyperammonemia in non-alcoholic fatty liver disease
Nadinskaia, M. Y., Okovityi, S. V., Александровна, П. В., Ф., Ш. А., Deeva, Т. A., Maevskaya, M. V., & Осипенко, М. Ф. (2026) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2026-204 · Cited by 1
Modeling Fibrosis with MASH Patient Liver-Derived OrganoidsPreprint
Liu, A., Haseman, A. D. T., Bantu, K., Nong, J., Muzykantov, V. R., Melamed, J. R., Kegel, M., Muscat-Rivera, J., Weissman, D., Smith, D. L., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.18.677209 · Cited by 1
Cyclin D1 regulates the hepatic response to feeding: Evidence for non-cell cycle roles in the liverPreprint
Wu, H., Hauser, J. I., Yang, N., Timchenko, N., Klaers, M., Salekeen, R., Manivel, J. C., Abrahante, J. E., Laux, L., Yousefzadeh, M. J., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.25.727739 · Cited by 1
The possible biomarkers of the «postСovid-19 syndrome» in patients with type 2 diabetes
Jburi, L. R., & Kopylova, M. V. (2022) · ТЕНДЕНЦИИ РАЗВИТИЯ НАУКИ И ОБРАЗОВАНИЯ · doi:10.18411/trnio-04-2022-88
Resolving Geroplasticity to the Balance of Rejuvenins and Geriatrins
TABIBZADEH, S. S. (2022) · Aging and Disease · doi:10.14336/ad.2022.0414
Coagulation meets senescence in NASH!
Anton, A., Shalaby, S., & Hernández–Gea, V. (2023) · Hepatology · doi:10.1097/hep.0000000000000498
Study on the Pathogenesis of Cell Senescence in Non-Alcoholic Fatty Liver
黄, 丽. (2024) · Medical Diagnosis · doi:10.12677/md.2024.141011
NK cell development and functional response during nonalcoholic steatohepatitis
Bourayou, E. (2023) · theses.fr (ABES) · doi:10.70675/9bf510f6z9823z4aaaza4bczb276b50278c4
Thapa, K. (2024) · UTUPub (University of Turku)
Poznyak, A. V., Orekhova, V. A., Korchagina, E. R., Maltseva, O. N., Pavshintsev, V. V., & Orekhov, A. N. (2025) · Journal of Carcinogenesis · doi:10.64149/j.carcinog.24.5s.472-487
Rôle de FAT10 dans la sénescence des hépatocytes et le développement de la NASH
Bernard, L. (2023) · theses.fr (ABES) · doi:10.70675/793b0b93z9794z42d4zb8dfz5f3d68268a9b
Qiu, X., Lu, Y., Tang, Y., Zhou, L., Lee, Y.-T., Meng, Z., Chen, Z., Pradeepa, F., Faccioli, L. A. P., Hu, Z., et al. (2026) · Journal of Clinical Investigation · doi:10.1172/jci199303 · Cited by 1
Yan, L., Sun, H., Wang, T., Chen, Y., & Li, P. J. (2026) · BMC Biotechnology · doi:10.1186/s12896-026-01162-w
Сергеевна, С. Е., Vinnitskaya, E. V., & Кhaimenova, T. Y. (2026) · Consilium Medicum · doi:10.26442/20751753.2026.5.203694
Li, J., Gao, M., Feng, J., Huo, D., Hong, R., 张复华, He, Q. J., & Dong, M. (2026) · Aging Cell · doi:10.1111/acel.70642
Tacke, F., Detjen, K. M., Heisig, J., & Hampe, J. (2026) · Zeitschrift für Gastroenterologie · doi:10.1055/a-2890-7253
Self-citationPeng, J., Yan, A., Chen, G., Gao, X., Yu, Q., Tian, W., & Cai, K. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1933792
Context-dependent duality of senescent cells in liver fibrosis
Gu, Y., Zhan, L., Di, Y., Wu, H., Zhao, T., Zhang, F., & Wu, Q. (2026) · Liver Research · doi:10.1016/j.livres.2026.09.001
Cheng, S., Zhao, Y., & Wang, W. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1982821
Shi, J., Zhao, C., Luo, L., Wang, H., Wei, P., Wang, X., Tong, Z., Zhu, S., Qing, Z., Li, R., et al. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1971381
Metadata
- Authors
- Engelmann, C., & Tacke, F.
- Affiliations
- Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE)
- Charité – Universitätsmedizin Berlin (DE)
- Corresponding author
- Engelmann, Cornelius
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-01-07
- Volume
- 23
- Issue
- 2
- Pages
- 652
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC8775400
- OpenAlex
- W4205372104
- Cited by
- 61
- References
- 90
- Citations by year
- 2026: 13 · 2025: 12 · 2024: 14 · 2023: 10 · 2022: 12
- FWCI
- 1.91
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Refubium (Universitätsbibliothek der Freien Universität Berlin) (submittedVersion, cc-by)
- Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver (cc-by)
- Funders
- Bristol-Myers Squibb
- Gilead Sciences
- CSL Behring
- Berlin Institute of Health
- Allergan
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- cellular senescence, non-alcoholic fatty liver disease, hepatocyte senescence, hepatic stellate cells, liver fibrosis, senescence-associated inflammation, extracellular matrix deposition, therapeutic target
- MeSH terms
- Extracellular Matrix, Humans, Cellular Senescence, Disease Progression, Hepatocytes, Hepatic Stellate Cells, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.